Publications by authors named "Lisa Agnello"

Claim this Profile
A
A red emitting carbon dot and aptamer-functionalized alginate system for targeted triple-negative breast cancer imaging.
Simone Maturi, Alessandra Caliendo, Silvia Tortorella, Nina Kostevšek, Erica Locatelli, Lisa Agnello

Biomater Sci· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A novel CD44-targeting aptamer recognizes chemoresistant mesenchymal stem-like TNBC cells and inhibits tumor growth.
Alessandra Caliendo, Simona Camorani, Luis Exequiel Ibarra, Gabriella Pinto, Lisa Agnello

Bioact Mater· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: Ibarra et al. Selective Photo-Assisted Eradication of Triple-Negative Breast Cancer Cells through Aptamer Decoration of Doped Conjugated Polymer Nanoparticles. 2022, , 626.
Luis Exequiel Ibarra, Simona Camorani, Lisa Agnello, Emilia Pedone, Luciano Pirone

Pharmaceutics· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: Bispecifc aptamer-decorated and light-triggered nanoparticles targeting tumor and stromal cells in breast cancer derived organoids: implications for precision phototherapies.
Simona Camorani, Alessandra Caliendo, Elena Morrone, Lisa Agnello, Matteo Martini

J Exp Clin Cancer Res· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bispecific aptamer-decorated and light-triggered nanoparticles targeting tumor and stromal cells in breast cancer derived organoids: implications for precision phototherapies.
Simona Camorani, Alessandra Caliendo, Elena Morrone, Lisa Agnello, Matteo Martini

J Exp Clin Cancer Res· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tissue Inhibitor of Metalloproteinases-1 Overexpression Mediates Chemoresistance in Triple-Negative Breast Cancer Cells.
Lisa Agnello, Annachiara d'Argenio, Alessandra Caliendo, Roberto Nilo, Antonella Zannetti

Cells· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Aptamer-Based Strategies to Boost Immunotherapy in TNBC.
Lisa Agnello, Annachiara d'Argenio, Roberto Nilo, Monica Fedele, Simona Camorani

Cancers (Basel)· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Aptamer-Functionalized Nanoparticles Mediate PD-L1 siRNA Delivery for Effective Gene Silencing in Triple-Negative Breast Cancer Cells.
Simona Camorani, Silvia Tortorella, Lisa Agnello, Chiara Spanu, Annachiara d'Argenio

Pharmaceutics· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Selective Photo-Assisted Eradication of Triple-Negative Breast Cancer Cells through Aptamer Decoration of Doped Conjugated Polymer Nanoparticles.
Luis Exequiel Ibarra, Simona Camorani, Lisa Agnello, Emilia Pedone, Luciano Pirone

Pharmaceutics· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimization of Short RNA Aptamers for TNBC Cell Targeting.
Simona Camorani, Annachiara d'Argenio, Lisa Agnello, Roberto Nilo, Antonella Zannetti

Int J Mol Sci· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Profiling Cancer Cells by Cell-SELEX: Use of Aptamers for Discovery of Actionable Biomarkers and Therapeutic Applications Thereof.
Sarah Shigdar, Lisa Agnello, Monica Fedele, Simona Camorani, Laura Cerchia

Pharmaceutics· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimizing cisplatin delivery to triple-negative breast cancer through novel EGFR aptamer-conjugated polymeric nanovectors.
Lisa Agnello, Silvia Tortorella, Annachiara d'Argenio, Clarissa Carbone, Simona Camorani

J Exp Clin Cancer Res· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Aptamers and antibodies: rivals or allies in cancer targeted therapy?
Lisa Agnello, Simona Camorani, Monica Fedele, Laura Cerchia

Explor Target Antitumor Ther· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Aptamer targeted therapy potentiates immune checkpoint blockade in triple-negative breast cancer.
Simona Camorani, Margherita Passariello, Lisa Agnello, Silvia Esposito, Francesca Collina

J Exp Clin Cancer Res· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis